Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma

Abstract Background The safety and efficacy of transarterial chemoembolization plus molecular targeted therapy (MTT) combined with immune checkpoint inhibitors (ICIs) in primary liver cancer have been demonstrated. However, the evidence for TACE plus MTT combined with ICIs in the treatment of recurr...

Descripció completa

Dades bibliogràfiques
Autors principals: Changlong Hou, Baizhu Xiong, Lei Zhou, Yipeng Fei, Changgao Shi, Xianhai Zhu, Tao Xie, Yulin Wu
Format: Article
Idioma:English
Publicat: BMC 2024-03-01
Col·lecció:BMC Cancer
Matèries:
Hepatocellular carcinoma
Transarterial chemoembolization
Targeted therapy
Immune checkpoint inhibitors
Interventional treatment
Accés en línia:https://doi.org/10.1186/s12885-024-12144-6

Internet

https://doi.org/10.1186/s12885-024-12144-6

Ítems similars